Gachon University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Seongnam Korea, Republic of (1939)

Organization Overview

First Clinical Trial
2003
NCT00356395
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Cardiology, Gil Heart Center, Gachon Medical School | Chan-Yong Jeon | Clinical Trials Center, Gil Medical Center, Incheon, Korea | GachonGill Medical Center | Gachon Kil Medical Center | Gachon University Gil Medical Center | Gachon University Gil Medical Center, Incheon, Korea | Gachon University Gil Medical Center, Incheon, Republic of Korea | Gachon University Gil Oriental Medical Hospital | Gachon University Gil Oriental Medicine Hospital | Gachon University Medical Center | Gachon university of Gil oriental hospital | Gachon University of Medicine and Science | Gachon University of Medicine and Science Gil Medical Center | Gachon University of Oriental Hospital | Gil Medical Center | Gil Medical Center Gachon University | Kyungmi Kim

Active Ingredients

Drugs in Phase 4 Trials (32)

acetylsalicylic acid (aspirin) (2 trials)

adefovir dipivoxil (hepsera) (1 trial)

amosartan (1 trial)

atenolol (tenormin) (1 trial)

candesartan (atacand) (1 trial)

carvedilol (coreg) (1 trial)

clopidogrel (plavix) (1 trial)

conjugated linoleic acid (1 trial)

daesiho-tang (1 trial)

danggui-sayuk-ga-osuyu-saenggang-tang (1 trial)

dexmedetomidine (precedex) (5 trials)

entecavir (baraclude) (3 trials)

everolimus (zortress) (1 trial)

ezetimibe (zetia) (4 trials)

fatty acid (1 trial)

fenofibrate (fenoglide) (4 trials)

granisetron (kytril) (1 trial)

icosapent ethyl (vascepa) (3 trials)

iloprost (ventavis) (1 trial)

imatinib (gleevec) (1 trial)

jowiseungcheung-tang (1 trial)

lamivudine (epivir) (1 trial)

losartan (cozaar) (1 trial)

pitavastatin (livalo) (1 trial)

pravastatin (pravachol) (3 trials)

ramipril (altace) (1 trial)

rosuvastatin (crestor) (5 trials)

simvastatin (zocor) (3 trials)

sirolimus (rapamune) (2 trials)

sogyeonghwalhyeol-tang (2 trials)

thioctic acid (1 trial)

valsartan (diovan) (1 trial)

Drugs in Phase 3 Trials (30)

amlodipine (norvasc) (3 trials)

atorvastatin (lipitor) (1 trial)

blood plasma (1 trial)

bosinji (1 trial)

capecitabine (xeloda) (3 trials)

celecoxib (celebrex) (2 trials)

cellulose (1 trial)

cisplatin (platinol) (4 trials)

ckd-825 (1 trial)

euiiyin-tang (1 trial)

fimasartan (kanarb) (2 trials)

follitropin alfa (1 trial)

gemcitabine (gemzar) (4 trials)

gimeracil (4 trials)

gv 1001 (1 trial)

hydrochlorothiazide (esidrix) (1 trial)

je-vax (1 trial)

levamlodipine (Conjupri) (1 trial)

moxifloxacin (avelox) (1 trial)

nbp607 (1 trial)

ojeok-san (1 trial)

olmesartan (benicar) (1 trial)

oteracil (4 trials)

oxaliplatin (eloxatin) (3 trials)

probiotic l sakei kctc 10755bp (1 trial)

s-1 (4 trials)

sipjeondaebo-tang (1 trial)

sodium chloride (4 trials)

tegafur (4 trials)

zabofloxacin (1 trial)

Drugs in Phase 2 Trials (23)

avelumab (bavencio) (1 trial)

bendamustine (treanda) (1 trial)

bevacizumab (avastin) (1 trial)

bortezomib (velcade) (1 trial)

ckd602 (1 trial)

curcumin (1 trial)

docetaxel (taxotere) (2 trials)

doxorubicin (Doxil) (1 trial)

esomeprazole (nexium) (1 trial)

fentanyl (Innovar) (1 trial)

fluorouracil (efudex) (2 trials)

gefitinib (iressa) (2 trials)

ifosfamide (ifex) (1 trial)

irinotecan (Camptosar) (5 trials)

leucovorin (2 trials)

oxycodone (oxycontin) (1 trial)

paclitaxel (taxol) (3 trials)

pemetrexed (alimta) (1 trial)

poziotinib (1 trial)

rituximab (rituxan) (1 trial)

sitagliptin (januvia) (1 trial)

tacrolimus (prograf) (1 trial)

topotecan (hycamtin) (1 trial)

Drugs in Phase 1 Trials (12)

allogeneic adipose derived mesenchymal stem cell (1 trial)

cat epidermis allergen (3 trials)

cetirizine (zyrtec) (1 trial)

ciclesonide (alvesco) (1 trial)

ckd-386 (1 trial)

dog allergen (3 trials)

house dust mite allergen (3 trials)

nvp-1203 (1 trial)

nvp-1402 (1 trial)

nvp-1805 (1 trial)

tegoprazan (1 trial)

tocilizumab (actemra) (1 trial)

Drugs in Other Trials (22)

actinidia arguta (1 trial)

alfentanil (alfenta) (1 trial)

angelica gigas nakai (1 trial)

aprepitant (Emend) (1 trial)

atropine (1 trial)

cinnamon bark (1 trial)

clarithromycin (biaxin) (1 trial)

cnidium rhizome (1 trial)

daclatasvir (daklinza) (1 trial)

desflurane (suprane) (1 trial)

epinephrine (levophed) (2 trials)

levofloxacin (levaquin) (1 trial)

lidocaine (xylocaine) (2 trials)

magnesium sulfate (Tis-U-Sol) (1 trial)

midazolam (versed) (1 trial)

orlistat (xenical) (1 trial)

propofol (diprivan) (2 trials)

remifentanil (ultiva) (1 trial)

rocuronium (zemuron) (1 trial)

sibutramine (meridia) (1 trial)

sunvepra (1 trial)

urea (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Kidney Injury (Phase 3)

Angina Pectoris (Phase 4)

Angina, Stable (Phase 4)

Anovulation (Phase 3)

Arthritis (Phase 3)

Arthritis, Juvenile (Phase 3)

Arthritis, Psoriatic (Phase 3)

Atrial Fibrillation (Phase 3)

Back Pain (Phase 4)

Breast Neoplasms (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Colorectal Neoplasms (Phase 3)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 3)

Cryopyrin-Associated Periodic Syndromes (Phase 4)

Dermatitis (Phase 3)

Dermatitis, Atopic (Phase 3)

Diabetic Neuropathies (Phase 4)

Dyslipidemias (Phase 1)

Eczema (Phase 3)

Encephalitis (Phase 3)

Encephalitis, Japanese (Phase 3)

Essential Hypertension (Phase 3)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Hypercholesterolemia (Phase 4)

Hyperlipidemia, Familial Combined (Phase 3)

Hyperlipidemias (Phase 3)

Hyperlipoproteinemias (Phase 3)

Hypersensitivity (Phase 4)

Hypertension (Phase 4)

Hypertriglyceridemia (Phase 4)

Infertility (Phase 3)

Influenza, Human (Phase 3)

Ischemia (Phase 1)

Kidney Diseases (Phase 4)

Leiomyosarcoma (Phase 2)

Leukemia (Phase 4)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 4)

Leukemia, Myeloid (Phase 4)

Leukemia, Myeloid, Accelerated Phase (Phase 2)

Leukemia, Myeloid, Chronic-Phase (Phase 2)

Liver Diseases (Phase 1)

Low Back Pain (Phase 4)

Lung Diseases (Phase 3)

Lung Diseases, Obstructive (Phase 3)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, B-Cell, Marginal Zone (Phase 2)

Metabolic Syndrome (Phase 4)

Multiple Myeloma (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Myocardial Ischemia (Phase 3)

Nausea (Phase 4)

Neoplasm Metastasis (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Obesity (Phase 3)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Pancreatic Neoplasms (Phase 3)

Pulmonary Disease, Chronic Obstructive (Phase 3)

Renal Insufficiency (Phase 4)

Renal Insufficiency, Chronic (Phase 3)

Rhinitis (Phase 1)

Rhinitis, Allergic (Phase 1)

Small Cell Lung Carcinoma (Phase 2)

Spondylitis (Phase 3)

Spondylitis, Ankylosing (Phase 3)

Stomach Neoplasms (Phase 3)

Syndrome (Phase 4)

Vomiting (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 103
  • # of Trial APIs: 119